Recombinant Proteins Market Share, Size, Trends, Industry Analysis Report, By Product & Services (Product, Production Services); By Application; By End-Use; By Region; Segment Forecast, 2022 - 2030
Description
The global recombinant proteins market size is expected to reach USD 7.53 billion by 2034, according to a new study by Polaris Market Research. The report “Recombinant Proteins Market Share, Size, Trends, Industry Analysis Report, By Product & Services (Product, Production Services), By Application, By End Use, and By Region -Market Forecast, 2025 - 2034” gives a detailed insight into current market dynamics and provides an analysis of future market growth.
A significant increase in government funding, increased R&D spending by pharmaceutical companies, and increasing non-communicable and chronic illnesses is expected to drive demand. Furthermore, the availability of a diverse range of innovations from human and animal sources and the rising demand for biological products is expected to drive industry growth.
In addition, other factors that are expected to complement growth opportunities include growing interest in personalized medicine and protein therapeutics. Several countries in Asia Pacific, including India, China, Japan, and South Korea, are likely to influence industry growth positively. However, decreasing the cost of the product may have some limitations, likely restraining industry growth.
The COVID-19 pandemic benefited the industry due very high number of coronavirus infections. It has allowed several research units to develop various combinations of recombination protein subunits, leading to a huge rise in demand for the product.
Recombinant Proteins Market Report Highlights
The demand for the therapeutics segment is expected to drive the revenue growth as demand for effective and convenient treatments is expected to witness growth over the forecast period
The enzymes segment accounted for the highest revenue share in 2024 and is expected to continue its dominance owing to the usage of enzymes in many research domains such as wound repairs, oncology, and other diseases
The pharmaceutical & biotech companies segment is expected to spearhead revenue growth to forecast and diagnose drug research more frequently
Asia Pacific is expected to witness substantial growth over the forecast period on account of several non-curable illnesses that are increasing across developing economies like India and China with increasing R&D initiatives
Major players operating in the industry include Abcam plc, Abnova Corp, Aviva systems biology, Bio-Techne corporation, Bio-Rad laboratories, Elpiscience, Elevian inc, Eli Lilly and co, Enzo life sciences, Inc, Gigagen inc, Genscript, Janssen-Cilag pty ltd, Merck KGaA, Proteinrech Group, Inc, R&D System, Inc, Raybiotech Life Inc., Stemcell Technologies Inc, Sino Biological Inc, Thermo Fisher Scientific, and U Protein Express
Polaris Market Research has segmented the recombinant proteins market report based on product & services, application, end-use, and region:
Recombinant Proteins, Product & Services Outlook (Revenue - USD Billion, 2020 - 2034)
Product
Cytokines & Growth Factors
Interferons (IFNs)
Interleukins (ILs)
Others
Antibodies
Immune Checkpoint Proteins
Virus Antigens
Enzymes
Kinases
Metabolic Enzymes
Others
Recombinant Regulatory Proteins
Hormones
Others
Production Services
Recombinant Proteins, Application Outlook (Revenue - USD Billion, 2020 - 2034)
Drug Discovery & Development
Therapeutics
Biologics
Vaccines
Cell & Gene Therapies
Others
Research
Others
Recombinant Proteins, End-Use Outlook (Revenue - USD Billion, 2020 - 2034)
Pharmaceutical & Biotechnology Companies
Academic & Research Institutes
Diagnostic Laboratories
Others
Recombinant Proteins, Regional Outlook (Revenue - USD Billion, 2020 - 2034)
North America
U.S
Canada
Europe
Germany
UK
France
Italy
Spain
Russia
Netherlands
Asia Pacific
China
India
Japan
South Korea
Indonesia
Malaysia
Latin America
Argentina
Brazil
Mexico
Middle East & Africa
UAE
Saudi Arabia
Israel
South Africa
A significant increase in government funding, increased R&D spending by pharmaceutical companies, and increasing non-communicable and chronic illnesses is expected to drive demand. Furthermore, the availability of a diverse range of innovations from human and animal sources and the rising demand for biological products is expected to drive industry growth.
In addition, other factors that are expected to complement growth opportunities include growing interest in personalized medicine and protein therapeutics. Several countries in Asia Pacific, including India, China, Japan, and South Korea, are likely to influence industry growth positively. However, decreasing the cost of the product may have some limitations, likely restraining industry growth.
The COVID-19 pandemic benefited the industry due very high number of coronavirus infections. It has allowed several research units to develop various combinations of recombination protein subunits, leading to a huge rise in demand for the product.
Recombinant Proteins Market Report Highlights
The demand for the therapeutics segment is expected to drive the revenue growth as demand for effective and convenient treatments is expected to witness growth over the forecast period
The enzymes segment accounted for the highest revenue share in 2024 and is expected to continue its dominance owing to the usage of enzymes in many research domains such as wound repairs, oncology, and other diseases
The pharmaceutical & biotech companies segment is expected to spearhead revenue growth to forecast and diagnose drug research more frequently
Asia Pacific is expected to witness substantial growth over the forecast period on account of several non-curable illnesses that are increasing across developing economies like India and China with increasing R&D initiatives
Major players operating in the industry include Abcam plc, Abnova Corp, Aviva systems biology, Bio-Techne corporation, Bio-Rad laboratories, Elpiscience, Elevian inc, Eli Lilly and co, Enzo life sciences, Inc, Gigagen inc, Genscript, Janssen-Cilag pty ltd, Merck KGaA, Proteinrech Group, Inc, R&D System, Inc, Raybiotech Life Inc., Stemcell Technologies Inc, Sino Biological Inc, Thermo Fisher Scientific, and U Protein Express
Polaris Market Research has segmented the recombinant proteins market report based on product & services, application, end-use, and region:
Recombinant Proteins, Product & Services Outlook (Revenue - USD Billion, 2020 - 2034)
Product
Cytokines & Growth Factors
Interferons (IFNs)
Interleukins (ILs)
Others
Antibodies
Immune Checkpoint Proteins
Virus Antigens
Enzymes
Kinases
Metabolic Enzymes
Others
Recombinant Regulatory Proteins
Hormones
Others
Production Services
Recombinant Proteins, Application Outlook (Revenue - USD Billion, 2020 - 2034)
Drug Discovery & Development
Therapeutics
Biologics
Vaccines
Cell & Gene Therapies
Others
Research
Others
Recombinant Proteins, End-Use Outlook (Revenue - USD Billion, 2020 - 2034)
Pharmaceutical & Biotechnology Companies
Academic & Research Institutes
Diagnostic Laboratories
Others
Recombinant Proteins, Regional Outlook (Revenue - USD Billion, 2020 - 2034)
North America
U.S
Canada
Europe
Germany
UK
France
Italy
Spain
Russia
Netherlands
Asia Pacific
China
India
Japan
South Korea
Indonesia
Malaysia
Latin America
Argentina
Brazil
Mexico
Middle East & Africa
UAE
Saudi Arabia
Israel
South Africa
Table of Contents
112 Pages
- 1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
- 2. Executive Summary
- 2.1. Market Highlights
- 3. Research Methodology
- 3.1. Overview
- 3.1.1. Data Mining
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
- 4. Global Plasmid Purification Market Insights
- 4.1. Plasmid Purification Market – Market Snapshot
- 4.2. Plasmid Purification Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Rise in Gene and Cell Therapy
- 4.2.1.2. Growing Use of Recombinant Technology
- 4.2.2. Restraints and Challenges
- 4.2.2.1. High cost of advanced purification technologies
- 4.3. Porter’s Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTEL Analysis
- 4.5. Plasmid Purification Market Trends
- 4.6. Value Chain Analysis
- 4.7. COVID-19 Impact Analysis
- 5. Global Plasmid Purification Market, by Product & Service
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global Plasmid Purification Market, by Product & Service, 2020–2034 (USD Billion)
- 5.3. Products
- 5.3.1. Global Plasmid Purification Market, by Products, by Region, 2020–2034 (USD Billion)
- 5.3.2. Instruments
- 5.3.3. Kits & Reagents
- 5.4. Services
- 5.4.1. Global Plasmid Purification Market, by Services, by Region, 2020–2034 (USD Billion)
- 6. Global Plasmid Purification Market, by Grade
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global Plasmid Purification Market, by Grade, 2020–2034 (USD Billion)
- 6.3. Molecular Grade
- 6.3.1. Global Plasmid Purification Market, by Molecular Grade, by Region, 2020–2034 (USD Billion)
- 6.4. Transfection Grade
- 6.4.1. Global Plasmid Purification Market, by Transfection Grade, by Region, 2020–2034 (USD Billion)
- 7. Global Plasmid Purification Market, by Application
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Global Plasmid Purification Market, by Application, 2020–2034 (USD Billion)
- 7.3. Cloning & Protein Expression
- 7.3.1. Global Plasmid Purification Market, by Cloning & Protein Expression, by Region, 2020–2034 (USD Billion)
- 7.4. Transfection & Gene Editing
- 7.4.1. Global Plasmid Purification Market, by Transfection & Gene Editing, by Region, 2020–2034 (USD Billion)
- 7.5. Others
- 7.5.1. Global Plasmid Purification Market, by Others, by Region, 2020–2034 (USD Billion)
- 8. Global Plasmid Purification Market, by End-use
- 8.1. Key Findings
- 8.2. Introduction
- 8.2.1. Global Plasmid Purification Market, by End-use, 2020–2034 (USD Billion)
- 8.3. Pharmaceutical & Biotechnology Companies
- 8.3.1. Global Plasmid Purification Market, by Pharmaceutical & Biotechnology Companies, by Region, 2020–2034 (USD Billion)
- 8.4. Academic & Research Institutes
- 8.4.1. Global Plasmid Purification Market, by Academic & Research Institutes, by Region, 2020–2034 (USD Billion)
- 8.5. Contract Research Organizations
- 8.5.1. Global Plasmid Purification Market, by Contract Research Organizations, by Region, 2020–2034 (USD Billion)
- 9. Global Plasmid Purification Market, by Geography
- 9.1. Key Findings
- 9.2. Introduction
- 9.2.1. Plasmid Purification Market Assessment, By Geography, 2020–2034 (USD Billion)
- 9.3. Plasmid Purification Market – North America
- 9.3.1. North America: Plasmid Purification Market, by Product & Service, 2020–2034 (USD Billion)
- 9.3.2. North America: Plasmid Purification Market, by Grade, 2020–2034 (USD Billion)
- 9.3.3. North America: Plasmid Purification Market, by Application, 2020–2034 (USD Billion)
- 9.3.4. North America: Plasmid Purification Market, by End-use, 2020–2034 (USD Billion)
- 9.3.5. Plasmid Purification Market – US
- 9.3.5.1. US: Plasmid Purification Market, by Product & Service, 2020–2034 (USD Billion)
- 9.3.5.2. US: Plasmid Purification Market, by Grade, 2020–2034 (USD Billion)
- 9.3.5.3. US: Plasmid Purification Market, by Application, 2020–2034 (USD Billion)
- 9.3.5.4. US: Plasmid Purification Market, by End-use, 2020–2034 (USD Billion)
- 9.3.6. Plasmid Purification Market – Canada
- 9.3.6.1. Canada: Plasmid Purification Market, by Product & Service, 2020–2034 (USD Billion)
- 9.3.6.2. Canada: Plasmid Purification Market, by Grade, 2020–2034 (USD Billion)
- 9.3.6.3. Canada: Plasmid Purification Market, by Application, 2020–2034 (USD Billion)
- 9.3.6.4. Canada: Plasmid Purification Market, by End-use, 2020–2034 (USD Billion)
- 9.4. Plasmid Purification Market – Europe
- 9.4.1. Europe: Plasmid Purification Market, by Product & Service, 2020–2034 (USD Billion)
- 9.4.2. Europe: Plasmid Purification Market, by Grade, 2020–2034 (USD Billion)
- 9.4.3. Europe: Plasmid Purification Market, by Application, 2020–2034 (USD Billion)
- 9.4.4. Europe: Plasmid Purification Market, by End-use, 2020–2034 (USD Billion)
- 9.4.5. Plasmid Purification Market – UK
- 9.4.5.1. UK: Plasmid Purification Market, by Product & Service, 2020–2034 (USD Billion)
- 9.4.5.2. UK: Plasmid Purification Market, by Grade, 2020–2034 (USD Billion)
- 9.4.5.3. UK: Plasmid Purification Market, by Application, 2020–2034 (USD Billion)
- 9.4.5.4. UK: Plasmid Purification Market, by End-use, 2020–2034 (USD Billion)
- 9.4.6. Plasmid Purification Market – France
- 9.4.6.1. France: Plasmid Purification Market, by Product & Service, 2020–2034 (USD Billion)
- 9.4.6.2. France: Plasmid Purification Market, by Grade, 2020–2034 (USD Billion)
- 9.4.6.3. France: Plasmid Purification Market, by Application, 2020–2034 (USD Billion)
- 9.4.6.4. France: Plasmid Purification Market, by End-use, 2020–2034 (USD Billion)
- 9.4.7. Plasmid Purification Market – Germany
- 9.4.7.1. Germany: Plasmid Purification Market, by Product & Service, 2020–2034 (USD Billion)
- 9.4.7.2. Germany: Plasmid Purification Market, by Grade, 2020–2034 (USD Billion)
- 9.4.7.3. Germany: Plasmid Purification Market, by Application, 2020–2034 (USD Billion)
- 9.4.7.4. Germany: Plasmid Purification Market, by End-use, 2020–2034 (USD Billion)
- 9.4.8. Plasmid Purification Market – Italy
- 9.4.8.1. Italy: Plasmid Purification Market, by Product & Service, 2020–2034 (USD Billion)
- 9.4.8.2. Italy: Plasmid Purification Market, by Grade, 2020–2034 (USD Billion)
- 9.4.8.3. Italy: Plasmid Purification Market, by Application, 2020–2034 (USD Billion)
- 9.4.8.4. Italy: Plasmid Purification Market, by End-use, 2020–2034 (USD Billion)
- 9.4.9. Plasmid Purification Market – Spain
- 9.4.9.1. Spain: Plasmid Purification Market, by Product & Service, 2020–2034 (USD Billion)
- 9.4.9.2. Spain: Plasmid Purification Market, by Grade, 2020–2034 (USD Billion)
- 9.4.9.3. Spain: Plasmid Purification Market, by Application, 2020–2034 (USD Billion)
- 9.4.9.4. Spain: Plasmid Purification Market, by End-use, 2020–2034 (USD Billion)
- 9.4.10. Plasmid Purification Market – Netherlands
- 9.4.10.1. Netherlands: Plasmid Purification Market, by Product & Service, 2020–2034 (USD Billion)
- 9.4.10.2. Netherlands: Plasmid Purification Market, by Grade, 2020–2034 (USD Billion)
- 9.4.10.3. Netherlands: Plasmid Purification Market, by Application, 2020–2034 (USD Billion)
- 9.4.10.4. Netherlands: Plasmid Purification Market, by End-use, 2020–2034 (USD Billion)
- 9.4.11. Plasmid Purification Market – Russia
- 9.4.11.1. Russia: Plasmid Purification Market, by Product & Service, 2020–2034 (USD Billion)
- 9.4.11.2. Russia: Plasmid Purification Market, by Grade, 2020–2034 (USD Billion)
- 9.4.11.3. Russia: Plasmid Purification Market, by Application, 2020–2034 (USD Billion)
- 9.4.11.4. Russia: Plasmid Purification Market, by End-use, 2020–2034 (USD Billion)
- 9.4.12. Plasmid Purification Market – Rest of Europe
- 9.4.12.1. Rest of Europe: Plasmid Purification Market, by Product & Service, 2020–2034 (USD Billion)
- 9.4.12.2. Rest of Europe: Plasmid Purification Market, by Grade, 2020–2034 (USD Billion)
- 9.4.12.3. Rest of Europe: Plasmid Purification Market, by Application, 2020–2034 (USD Billion)
- 9.4.12.4. Rest of Europe: Plasmid Purification Market, by End-use, 2020–2034 (USD Billion)
- 9.5. Plasmid Purification Market – Asia Pacific
- 9.5.1. Asia Pacific: Plasmid Purification Market, by Product & Service, 2020–2034 (USD Billion)
- 9.5.2. Asia Pacific: Plasmid Purification Market, by Grade, 2020–2034 (USD Billion)
- 9.5.3. Asia Pacific: Plasmid Purification Market, by Application, 2020–2034 (USD Billion)
- 9.5.4. Asia Pacific: Plasmid Purification Market, by End-use, 2020–2034 (USD Billion)
- 9.5.5. Plasmid Purification Market – China
- 9.5.5.1. China: Plasmid Purification Market, by Product & Service, 2020–2034 (USD Billion)
- 9.5.5.2. China: Plasmid Purification Market, by Grade, 2020–2034 (USD Billion)
- 9.5.5.3. China: Plasmid Purification Market, by Application, 2020–2034 (USD Billion)
- 9.5.5.4. China: Plasmid Purification Market, by End-use, 2020–2034 (USD Billion)
- 9.5.6. Plasmid Purification Market – India
- 9.5.6.1. India: Plasmid Purification Market, by Product & Service, 2020–2034 (USD Billion)
- 9.5.6.2. India: Plasmid Purification Market, by Grade, 2020–2034 (USD Billion)
- 9.5.6.3. India: Plasmid Purification Market, by Application, 2020–2034 (USD Billion)
- 9.5.6.4. India: Plasmid Purification Market, by End-use, 2020–2034 (USD Billion)
- 9.5.7. Plasmid Purification Market – Malaysia
- 9.5.7.1. Malaysia: Plasmid Purification Market, by Product & Service, 2020–2034 (USD Billion)
- 9.5.7.2. Malaysia: Plasmid Purification Market, by Grade, 2020–2034 (USD Billion)
- 9.5.7.3. Malaysia: Plasmid Purification Market, by Application, 2020–2034 (USD Billion)
- 9.5.7.4. Malaysia: Plasmid Purification Market, by End-use, 2020–2034 (USD Billion)
- 9.5.8. Plasmid Purification Market – Japan
- 9.5.8.1. Japan: Plasmid Purification Market, by Product & Service, 2020–2034 (USD Billion)
- 9.5.8.2. Japan: Plasmid Purification Market, by Grade, 2020–2034 (USD Billion)
- 9.5.8.3. Japan: Plasmid Purification Market, by Application, 2020–2034 (USD Billion)
- 9.5.8.4. Japan: Plasmid Purification Market, by End-use, 2020–2034 (USD Billion)
- 9.5.9. Plasmid Purification Market – Indonesia
- 9.5.9.1. Indonesia: Plasmid Purification Market, by Product & Service, 2020–2034 (USD Billion)
- 9.5.9.2. Indonesia: Plasmid Purification Market, by Grade, 2020–2034 (USD Billion)
- 9.5.9.3. Indonesia: Plasmid Purification Market, by Application, 2020–2034 (USD Billion)
- 9.5.9.4. Indonesia: Plasmid Purification Market, by End-use, 2020–2034 (USD Billion)
- 9.5.10. Plasmid Purification Market – South Korea
- 9.5.10.1. South Korea: Plasmid Purification Market, by Product & Service, 2020–2034 (USD Billion)
- 9.5.10.2. South Korea: Plasmid Purification Market, by Grade, 2020–2034 (USD Billion)
- 9.5.10.3. South Korea: Plasmid Purification Market, by Application, 2020–2034 (USD Billion)
- 9.5.10.4. South Korea: Plasmid Purification Market, by End-use, 2020–2034 (USD Billion)
- 9.5.11. Plasmid Purification Market – Australia
- 9.5.11.1. Australia: Plasmid Purification Market, by Product & Service, 2020–2034 (USD Billion)
- 9.5.11.2. Australia: Plasmid Purification Market, by Grade, 2020–2034 (USD Billion)
- 9.5.11.3. Australia: Plasmid Purification Market, by Application, 2020–2034 (USD Billion)
- 9.5.11.4. Australia: Plasmid Purification Market, by End-use, 2020–2034 (USD Billion)
- 9.5.12. Plasmid Purification Market – Rest of Asia Pacific
- 9.5.12.1. Rest of Asia Pacific: Plasmid Purification Market, by Product & Service, 2020–2034 (USD Billion)
- 9.5.12.2. Rest of Asia Pacific: Plasmid Purification Market, by Grade, 2020–2034 (USD Billion)
- 9.5.12.3. Rest of Asia Pacific: Plasmid Purification Market, by Application, 2020–2034 (USD Billion)
- 9.5.12.4. Rest of Asia Pacific: Plasmid Purification Market, by End-use, 2020–2034 (USD Billion)
- 9.6. Plasmid Purification Market – Middle East & Africa
- 9.6.1. Middle East & Africa: Plasmid Purification Market, by Product & Service, 2020–2034 (USD Billion)
- 9.6.2. Middle East & Africa: Plasmid Purification Market, by Grade, 2020–2034 (USD Billion)
- 9.6.3. Middle East & Africa: Plasmid Purification Market, by Application, 2020–2034 (USD Billion)
- 9.6.4. Middle East & Africa: Plasmid Purification Market, by End-use, 2020–2034 (USD Billion)
- 9.6.5. Plasmid Purification Market – Saudi Arabia
- 9.6.5.1. Saudi Arabia: Plasmid Purification Market, by Product & Service, 2020–2034 (USD Billion)
- 9.6.5.2. Saudi Arabia: Plasmid Purification Market, by Grade, 2020–2034 (USD Billion)
- 9.6.5.3. Saudi Arabia: Plasmid Purification Market, by Application, 2020–2034 (USD Billion)
- 9.6.5.4. Saudi Arabia: Plasmid Purification Market, by End-use, 2020–2034 (USD Billion)
- 9.6.6. Plasmid Purification Market – UAE
- 9.6.6.1. UAE: Plasmid Purification Market, by Product & Service, 2020–2034 (USD Billion)
- 9.6.6.2. UAE: Plasmid Purification Market, by Grade, 2020–2034 (USD Billion)
- 9.6.6.3. UAE: Plasmid Purification Market, by Application, 2020–2034 (USD Billion)
- 9.6.6.4. UAE: Plasmid Purification Market, by End-use, 2020–2034 (USD Billion)
- 9.6.7. Plasmid Purification Market – Israel
- 9.6.7.1. Israel: Plasmid Purification Market, by Product & Service, 2020–2034 (USD Billion)
- 9.6.7.2. Israel: Plasmid Purification Market, by Grade, 2020–2034 (USD Billion)
- 9.6.7.3. Israel: Plasmid Purification Market, by Application, 2020–2034 (USD Billion)
- 9.6.7.4. Israel: Plasmid Purification Market, by End-use, 2020–2034 (USD Billion)
- 9.6.8. Plasmid Purification Market – South Africa
- 9.6.8.1. South Africa: Plasmid Purification Market, by Product & Service, 2020–2034 (USD Billion)
- 9.6.8.2. South Africa: Plasmid Purification Market, by Grade, 2020–2034 (USD Billion)
- 9.6.8.3. South Africa: Plasmid Purification Market, by Application, 2020–2034 (USD Billion)
- 9.6.8.4. South Africa: Plasmid Purification Market, by End-use, 2020–2034 (USD Billion)
- 9.6.9. Plasmid Purification Market – Rest of Middle East & Africa
- 9.6.9.1. Rest of Middle East & Africa: Plasmid Purification Market, by Product & Service, 2020–2034 (USD Billion)
- 9.6.9.2. Rest of Middle East & Africa: Plasmid Purification Market, by Grade, 2020–2034 (USD Billion)
- 9.6.9.3. Rest of Middle East & Africa: Plasmid Purification Market, by Application, 2020–2034 (USD Billion)
- 9.6.9.4. Rest of Middle East & Africa: Plasmid Purification Market, by End-use, 2020–2034 (USD Billion)
- 9.7. Plasmid Purification Market – Latin America
- 9.7.1. Latin America: Plasmid Purification Market, by Product & Service, 2020–2034 (USD Billion)
- 9.7.2. Latin America: Plasmid Purification Market, by Grade, 2020–2034 (USD Billion)
- 9.7.3. Latin America: Plasmid Purification Market, by Application, 2020–2034 (USD Billion)
- 9.7.4. Latin America: Plasmid Purification Market, by End-use, 2020–2034 (USD Billion)
- 9.7.5. Plasmid Purification Market – Mexico
- 9.7.5.1. Mexico: Plasmid Purification Market, by Product & Service, 2020–2034 (USD Billion)
- 9.7.5.2. Mexico: Plasmid Purification Market, by Grade, 2020–2034 (USD Billion)
- 9.7.5.3. Mexico: Plasmid Purification Market, by Application, 2020–2034 (USD Billion)
- 9.7.5.4. Mexico: Plasmid Purification Market, by End-use, 2020–2034 (USD Billion)
- 9.7.6. Plasmid Purification Market – Brazil
- 9.7.6.1. Brazil: Plasmid Purification Market, by Product & Service, 2020–2034 (USD Billion)
- 9.7.6.2. Brazil: Plasmid Purification Market, by Grade, 2020–2034 (USD Billion)
- 9.7.6.3. Brazil: Plasmid Purification Market, by Application, 2020–2034 (USD Billion)
- 9.7.6.4. Brazil: Plasmid Purification Market, by End-use, 2020–2034 (USD Billion)
- 9.7.7. Plasmid Purification Market – Argentina
- 9.7.7.1. Argentina: Plasmid Purification Market, by Product & Service, 2020–2034 (USD Billion)
- 9.7.7.2. Argentina: Plasmid Purification Market, by Grade, 2020–2034 (USD Billion)
- 9.7.7.3. Argentina: Plasmid Purification Market, by Application, 2020–2034 (USD Billion)
- 9.7.7.4. Argentina: Plasmid Purification Market, by End-use, 2020–2034 (USD Billion)
- 9.7.8. Plasmid Purification Market – Rest of Latin America
- 9.7.8.1. Rest of Latin America: Plasmid Purification Market, by Product & Service, 2020–2034 (USD Billion)
- 9.7.8.2. Rest of Latin America: Plasmid Purification Market, by Grade, 2020–2034 (USD Billion)
- 9.7.8.3. Rest of Latin America: Plasmid Purification Market, by Application, 2020–2034 (USD Billion)
- 9.7.8.4. Rest of Latin America: Plasmid Purification Market, by End-use, 2020–2034 (USD Billion)
- 10. Competitive Landscape
- 10.1. Expansion and Acquisition Analysis
- 10.1.1. Expansion
- 10.1.2. Acquisitions
- 10.2. Partnerships/Collaborations/Agreements/Exhibitions
- 11. Company Profiles
- 11.1. Bio Inc.
- 11.1.1. Company Overview
- 11.1.2. Financial Performance
- 11.1.3. Product Benchmarking
- 11.1.4. Recent Development
- 11.2. Bio-Rad Laboratories, Inc.
- 11.2.1. Company Overview
- 11.2.2. Financial Performance
- 11.2.3. Product Benchmarking
- 11.2.4. Recent Development
- 11.3. Merck KGaA
- 11.3.1. Company Overview
- 11.3.2. Financial Performance
- 11.3.3. Product Benchmarking
- 11.3.4. Recent Development
- 11.4. New England Biolabs
- 11.4.1. Company Overview
- 11.4.2. Financial Performance
- 11.4.3. Product Benchmarking
- 11.4.4. Recent Development
- 11.5. Promega Corporation
- 11.5.1. Company Overview
- 11.5.2. Financial Performance
- 11.5.3. Product Benchmarking
- 11.5.4. Recent Development
- 11.6. QIAGEN N.V.
- 11.6.1. Company Overview
- 11.6.2. Financial Performance
- 11.6.3. Product Benchmarking
- 11.6.4. Recent Development
- 11.7. Thermo Fisher Scientific Inc.
- 11.7.1. Company Overview
- 11.7.2. Financial Performance
- 11.7.3. Product Benchmarking
- 11.7.4. Recent Development
- 11.8. Zymo Research Corporation
- 11.8.1. Company Overview
- 11.8.2. Financial Performance
- 11.8.3. Product Benchmarking
- 11.8.4. Recent Development
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
